Skip to main content

Pharmacy

By Susan Morse | 11:09 am | February 18, 2020
Millennials in particular want a discussion with their provider and will choose their physician based on the ability to discuss drug costs.
By Mark Klimek | 02:27 pm | February 06, 2020
Eleven drugs are potential blockbusters with an expected $1 billion in U.S. sales, according to the report.
By Susan Morse | 01:37 pm | February 06, 2020
Plan satisfaction will now have a greater effect on MA star ratings, as the Advance Notice proposes to double the value member satisfaction.
By Susan Morse | 03:56 pm | February 05, 2020
The president promised to protect Medicaid, yet his Administration's proposal to change the funding mechanism would cap funds, physician says.
By Jeff Lagasse | 03:05 pm | February 03, 2020
As commercial health plans and others fortify their strategy for preventive care, one opportunity is to leverage an existing retail footprint.
By Jeff Lagasse | 11:02 am | January 31, 2020
Opioid prescribing remains far higher in the U.S. than in other countries, despite efforts to reduce inappropriate prescribing.
By Dave Muoio, Mobihealth News | 06:37 pm | January 28, 2020
The Silicon Valley EHR vendor received "sponsorship" payments from unnamed pharmaceutical companies so that the latter's marketing team could influence the design of CDS features, according to the Department of Justice.
By Susan Morse | 04:14 pm | January 23, 2020
The 18 BCBS companies will provide $55 million to help create a Civica subsidiary focused on generic medications outside of the hospital setting.
By Jeff Lagasse | 03:21 pm | January 22, 2020
An interventionist approach from the government may not work as intended; market competition and systemic reform will be paramount.
By Jeff Lagasse | 11:54 am | January 20, 2020
Spending on cancer drugs was 2% to 5% higher than that of non-participants, and 1% to 7% higher than physician offices -- a modest effect on consumers.